[go: up one dir, main page]

DE60117247D1 - Phosphoramidat-prodrugs - Google Patents

Phosphoramidat-prodrugs

Info

Publication number
DE60117247D1
DE60117247D1 DE60117247T DE60117247T DE60117247D1 DE 60117247 D1 DE60117247 D1 DE 60117247D1 DE 60117247 T DE60117247 T DE 60117247T DE 60117247 T DE60117247 T DE 60117247T DE 60117247 D1 DE60117247 D1 DE 60117247D1
Authority
DE
Germany
Prior art keywords
compounds
phosphoramidate
phosphoramidate prodrugs
functional
peptidomimetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60117247T
Other languages
English (en)
Inventor
F Borch
C Tobias
Hugo Garrido-Hernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Application granted granted Critical
Publication of DE60117247D1 publication Critical patent/DE60117247D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/26—Amides of acids of phosphorus containing P-halide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60117247T 2000-03-31 2001-03-30 Phosphoramidat-prodrugs Expired - Fee Related DE60117247D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19391800P 2000-03-31 2000-03-31
PCT/US2001/010163 WO2001074827A1 (en) 2000-03-31 2001-03-30 Phosphoramidate prodrugs

Publications (1)

Publication Number Publication Date
DE60117247D1 true DE60117247D1 (de) 2006-04-20

Family

ID=22715556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60117247T Expired - Fee Related DE60117247D1 (de) 2000-03-31 2001-03-30 Phosphoramidat-prodrugs

Country Status (8)

Country Link
US (2) US6903081B2 (de)
EP (1) EP1268493B1 (de)
JP (1) JP2004538240A (de)
AT (1) ATE317846T1 (de)
AU (1) AU784462B2 (de)
CA (1) CA2397203A1 (de)
DE (1) DE60117247D1 (de)
WO (1) WO2001074827A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004130A1 (en) * 1999-07-14 2001-01-18 Purdue Research Foundation Phosphoramide compounds
JP2004538240A (ja) * 2000-03-31 2004-12-24 パーデュー・リサーチ・ファウンデーション ホスホラミデートおよびそのための方法
US8707406B2 (en) * 2002-07-26 2014-04-22 Sierra Wireless, Inc. Always-on virtual private network access
ZA200507752B (en) * 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
JP2008520575A (ja) * 2004-11-15 2008-06-19 セプタイア インコーポレイテッド プロテインチロシンホスファターゼ阻害剤およびその使用方法
EP1827460A4 (de) * 2004-12-09 2012-03-14 Univ Minnesota Nucleoside mit antiviraler und anti-krebs-wirkung
WO2006099313A2 (en) * 2005-03-14 2006-09-21 Purdue Research Foundation Phosphate conjugates of prenylation inhibitors
JP5180824B2 (ja) 2005-06-29 2013-04-10 スレッシュホールド ファーマシューティカルズ， インコーポレイテッド ホスホルアミデートアルキル化剤プロドラッグ
EP1928475B1 (de) 2005-08-15 2018-05-23 Riboscience LLC Antivirale phosphoramidate von 4'-c-azid-substituierten pronukleotiden
US8197545B2 (en) 2005-10-27 2012-06-12 Depuy Spine, Inc. Nucleus augmentation delivery device and technique
EP2114157B1 (de) * 2006-12-26 2021-05-26 ImmunoGenesis, Inc. Phosphoramidatalkylator-prodrug für die krebstherapie
US20090118031A1 (en) * 2007-11-01 2009-05-07 Qualizza Gregory K Shaft Structure with Configurable Bending Profile
DK3116511T3 (da) 2014-03-14 2020-11-23 Alltech Inc Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
WO2017048252A1 (en) 2015-09-15 2017-03-23 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
WO2018148754A1 (en) * 2017-02-13 2018-08-16 The Regents Of The University Of California Site-specific generation of phosphorylated tyrosines in proteins
EP4582558A4 (de) * 2022-10-31 2025-10-08 Genemind Biosciences Co Ltd Oberflächenbehandlungsverfahren, sequenzierungsverfahren und kit
GB2634858A (en) * 2023-08-09 2025-04-30 Biberchem Res Limited Method of synthesising plasmalogen compounds

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303189A (en) * 1965-03-11 1967-02-07 Smith Kline French Lab 2, 1-benzothiazine-2, 2-dioxides
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US5106855A (en) * 1989-12-20 1992-04-21 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US5233031A (en) 1991-09-23 1993-08-03 University Of Rochester Phosphoramidate analogs of 2'-deoxyuridine
GB9216380D0 (en) * 1992-07-31 1992-09-16 Glaxo Group Ltd Medicaments
US5290781A (en) * 1993-01-05 1994-03-01 Iolab Corporation Ketaneserinol as an agent to reduce intraocular pressure
US5344929A (en) * 1993-02-18 1994-09-06 Alcon Laboratories, Inc. Preparation of carbonic anhydrase inhibitors
US5306727A (en) * 1993-04-30 1994-04-26 Research Corporation Technologies, Inc. Phosphoramidates useful as antitumor agents
TW270114B (de) * 1993-10-22 1996-02-11 Hoffmann La Roche
TW334423B (en) * 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
US5538966A (en) * 1994-01-21 1996-07-23 Alcon Laboratories, Inc. Carbonic anhydrase inhibitors
US5538974A (en) * 1994-01-27 1996-07-23 Senju Pharamceutical Co., Ltd. Ophthalmic composition for lowering intraocular pressure
EP0686393B1 (de) * 1994-03-18 1998-05-20 Senju Pharmaceutical Co., Ltd. Sarpogrelat enthaltende opthalmologische Zubereitungen zur Senkung des intraokularen Druckes
CN1148853A (zh) * 1994-03-31 1997-04-30 日本化学医药株式会社 亚烷基二胺衍生物
TW403738B (en) * 1994-08-12 2000-09-01 Hoffmann La Roche Tricyclic pyrazole derivatives
US5470973A (en) * 1994-10-03 1995-11-28 Alcon Laboratories, Inc. Synthesis of sulfonamide intermediates
JP3232365B2 (ja) * 1995-02-20 2001-11-26 トキコ株式会社 ディスクブレーキ
US5880134A (en) * 1996-03-20 1999-03-09 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
JPH11193289A (ja) * 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
US6107324A (en) * 1998-04-14 2000-08-22 Arena Pharmaceuticals Inc. 5-HT2A receptor inverse agonists
ATE310566T1 (de) * 1998-09-18 2005-12-15 Alcon Mfg Ltd 5ht2-agoniste zur behandlung des glaukoms
US6806285B1 (en) * 2000-03-17 2004-10-19 Alcon, Inc. 5-Hydroxyl indole derivatives for treating glaucoma
US6660870B1 (en) * 2000-03-17 2003-12-09 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
JP2004538240A (ja) * 2000-03-31 2004-12-24 パーデュー・リサーチ・ファウンデーション ホスホラミデートおよびそのための方法
ATE318821T1 (de) * 2001-06-01 2006-03-15 Alcon Inc Pyranoindazole und ihre verwendung in der glaukombehandlung
US6884816B2 (en) * 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma

Also Published As

Publication number Publication date
JP2004538240A (ja) 2004-12-24
US20050171060A1 (en) 2005-08-04
AU4961601A (en) 2001-10-15
US6903081B2 (en) 2005-06-07
US7173020B2 (en) 2007-02-06
EP1268493B1 (de) 2006-02-15
AU784462B2 (en) 2006-04-06
WO2001074827A1 (en) 2001-10-11
EP1268493A1 (de) 2003-01-02
CA2397203A1 (en) 2001-10-11
US20020004594A1 (en) 2002-01-10
ATE317846T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
ATE317846T1 (de) Phosphoramidat-prodrugs
ATE513847T1 (de) Bioaktive peptide
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
MXPA01008937A (es) Nuevos profarmacos que contienen fosforo.
GB2340121B (en) Delivery system
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
BR0111438A (pt) Análogos de ácido barbitúrico como agentes terapeuticos
AU2845599A (en) Pharmaceutical compositions and their use
MX9601994A (es) Profarmacos de derivados de paclitaxel.
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
AU2002326070A1 (en) Peyers's patch and/or m-celle targeting ligands
ATE371737T1 (de) Proteaseresistente flint-analoge
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
DE60008415D1 (de) Zusammensetzung die mindestens ein stickstoffmonoxid-synthase inhibitor und mindestens ein phospholipase a2 inhibitor enthält zur herstellung eines medikamentes
BR0014831A (pt) Droga terapêutica para lesões refratárias, compreendendo uma substância com atividade inibidora de elastase leucocitária humana
ES2185083T3 (es) Proteina estimulante de macrofagos para el tratamiento de patologias del sistema nervioso.
ATE273014T1 (de) VERWENDUNG DER BIOAKTIVEN FRAKTION AUS DEM URINDESTILLAT DER KUH (ßGO MUTRAß) ZUR VERSTÄRKUNG DER WIRKSAMKEIT VON ANTI-INFEKTIVA, ANTI-KREBSMITTELN UND ERNÄHRUNGSMITTELN
SE9803271D0 (sv) A drug for well-being
ECSP951393A (es) UTILIZACION DE 2- AMINO 4,5,7,8- TETRAHIDRO -6H-TIAZOLO [5,4-d] AZEPINAS SUSTITUIDAS EN POSICION 6 COMO MEDICAMENTOS CON EFECTO ANTIDEPRESIVO Y SU PREPARACION

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee